US Court Protects Drug Maker's Sales
A new court decision stops some companies from bringing Gilead's drugs into the U.S. from other countries.
A U.S. appeals court made a big decision. This ruling helps a company called Gilead Sciences. Gilead makes important medicines. The court said certain programs cannot bring these drugs from overseas into the U.S.
These programs are called alternative funding programs. They used to buy medicines cheaper in other countries. Then they would bring them to America. This helped some people get lower prices on expensive drugs.
Now, the court says these programs must stop. This means Gilead keeps control over its drug sales in the U.S. It protects Gilead's business in America.
This decision affects how some people get their medicines. It changes how these programs work to help patients. The court's choice shows how important drug patents are in the U.S.
Source: CNBC
More from Biotech
